Evaluation of the Impact of Dietary Education and Intervention on Gout Patients Receiving Urate-Lowering Therapy
1 other identifier
interventional
300
1 country
1
Brief Summary
The goal of this interventional study is to learn whether dietary education and intervention can reduce blood uric acid levels in patients with gout. The main questions this study aims to answer are:
- Can dietary education and intervention reduce gout-related clinical laboratory results?
- Can dietary education and intervention improve BMI and SBP/DBP in participants with gout? In this study, participants will be divided into three groups, including a control group, and their outcomes compared, in order to determine whether a low-purine (low-uric-acid) diet and a DASH diet are effective in reducing blood uric acid levels in participants with gout. Participants will:
- Participate in the study for a total of 2 years, receiving dietary education and intervention according to their assigned group throughout this period
- Complete surveys, physical measurements, and receive dietary education once every 6 months
- Receive dietary education by phone and through an app, and complete surveys, once every month
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 26, 2025
CompletedFirst Submitted
Initial submission to the registry
September 17, 2026
CompletedFirst Posted
Study publicly available on registry
September 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2035
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2035
September 22, 2026
September 1, 2026
9.8 years
September 17, 2026
September 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Uric Acid Level
Measured in serum
Baseline, At 12-months, At 24-months
Secondary Outcomes (4)
Body Mass Index (kg/m^2)
Baseline, At 6-months, At 12-months, At 18-months, At 24-months
Systolic Blood Pressure(mmHg)
Baseline, At 6-months, At 12-months, At 18-months, At 24-months
Diastolic Blood Pressure (mmHg)
Baseline, At 6-months, At 12-months, At 18-months, At 24-months
Change in Purine-rich food Intake
Baseline, At 6-months, At 12-months, At 18-months, At 24-months
Study Arms (3)
Usual Diet and lifestyle
NO INTERVENTIONParticipants will maintain their usual diet and lifestyle without receiving a specific dietary intervention.
Low-Uric acid Diet
EXPERIMENTALThe low-uric-acid diet is designed to provide a higher daily purine intake than a low-purine diet. Participants will receive dietary education to limit the consumption of red meat, organ meats, seafood, and alcohol, while emphasizing plant-based foods such as vegetables, fruits, whole grains, and legumes.
DASH Diet
EXPERIMENTAL\*\*DASH Diet:\*\* Participants will be encouraged to consume lean meats, selected fish, vegetables, fruits, whole grains, low-fat dairy products, nuts, and legumes. They will also be asked to limit their intake of sodium, saturated fat, refined carbohydrates, and fatty meats.
Interventions
Participants will receive monthly reminders about dietary education and complete questionnaires to assess adherence to the assigned diet. * Every 6 months, participants will undergo measurements of body composition using bioelectrical impedance analysis, waist and hip circumference, and blood pressure during their scheduled outpatient visits to assess their health status. * Blood samples will be collected annually to assess the effects of the dietary intervention and education on participants' health. * Participants will receive KRW 40,000 in compensation for study participation every 12 months.
Participants will receive monthly reminders about dietary education and complete questionnaires to assess adherence to the assigned diet. * Every 6 months, participants will undergo measurements of body composition using bioelectrical impedance analysis, waist and hip circumference, and blood pressure during their scheduled outpatient visits to assess their health status. * Blood samples will be collected annually to assess the effects of the dietary intervention and education on participants' health. * Participants will receive KRW 40,000 in compensation for study participation every 12 months.
Eligibility Criteria
You may qualify if:
- Currently receiving urate-lowering therapy at this hospital
- Male, aged 19 years or older, with a history of at least one gout flare
You may not qualify if:
- Unwilling or unable to provide informed consent
- Life expectancy of less than 2years due to comorbid conditions
- Refusal of urate-lowering therapy
- Estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73m² or less (diagnosed with chronic kidney disease stage 3B or higher)
- E. Diagnosis of chronic obstructive pulmonary disease (COPD) or asthma within the past 6 months
- F. History of gastrointestinal disease (including inflammatory bowel disease, malabsorption, gastric bypass surgery, or major bowel resection)
- G. Currently receiving chemotherapy for cancer treatment
- H. Diagnosis of myocardial infarction, heart failure, or angina, or history of coronary artery bypass surgery or angioplasty, within the past 6 months
- I. Any other condition that, in the investigator's judgment, makes the participant unsuitable for this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sung Keon Cholead
Study Sites (1)
Ajou University Hospital
Suwon, Gyeonggi-do, 16499, South Korea
Related Publications (2)
Yokose C, McCormick N, Choi HK. The role of diet in hyperuricemia and gout. Curr Opin Rheumatol. 2021 Mar 1;33(2):135-144. doi: 10.1097/BOR.0000000000000779.
PMID: 33399399RESULTYokose C, McCormick N, Rai SK, Lu N, Curhan G, Schwarzfuchs D, Shai I, Choi HK. Effects of Low-Fat, Mediterranean, or Low-Carbohydrate Weight Loss Diets on Serum Urate and Cardiometabolic Risk Factors: A Secondary Analysis of the Dietary Intervention Randomized Controlled Trial (DIRECT). Diabetes Care. 2020 Nov;43(11):2812-2820. doi: 10.2337/dc20-1002. Epub 2020 Sep 2.
PMID: 33082244RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 17, 2026
First Posted
September 22, 2026
Study Start
March 26, 2025
Primary Completion (Estimated)
January 1, 2035
Study Completion (Estimated)
May 1, 2035
Last Updated
September 22, 2026
Record last verified: 2026-09